These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24673973)

  • 1. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.
    Nathwani D; Eckmann C; Lawson W; Stephens JM; Macahilig C; Solem CT; Simoneau D; Chambers R; Li JZ; Haider S
    Clin Microbiol Infect; 2014 Oct; 20(10):993-1000. PubMed ID: 24673973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe.
    Nathwani D; Eckmann C; Lawson W; Solem CT; Corman S; Stephens JM; Macahilig C; Simoneau D; Chambers R; Li JZ; Haider S
    BMC Infect Dis; 2014 Sep; 14():476. PubMed ID: 25182029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil.
    Furtado GH; Rocha J; Hayden R; Solem C; Macahilig C; Tang WY; Chambers R; Figueiredo MLN; Johnson C; Stephens J; Haider S
    Braz J Infect Dis; 2019; 23(2):86-94. PubMed ID: 31078574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.
    El Houfi A; Javed N; Solem CT; Macahilig C; Stephens JM; Raghubir N; Chambers R; Li JZ; Haider S
    Infect Drug Resist; 2015; 8():173-9. PubMed ID: 26124673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Eckmann C; Nathwani D; Lawson W; Corman S; Solem C; Stephens J; Macahilig C; Li J; Charbonneau C; Baillon-Plot N; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S33-9. PubMed ID: 26198370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early switch/early discharge opportunities for hospitalized patients with methicillin resistant Staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab Emirates.
    Houfi AE; Thaqafi AA; Alenazi TH; Farahat F; Solem CT; Stephens JM; Johnson C; Macahilig C; Tang WY; Haider S
    J Infect Public Health; 2020 Aug; 13(8):1126-1133. PubMed ID: 32482613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
    Lawson W; Nathwani D; Eckmann C; Corman S; Stephens J; Solem C; Macahilig C; Li J; Baillon-Plot N; Charbonneau C; Haider S
    Clin Microbiol Infect; 2015 Sep; 21 Suppl 2():S40-6. PubMed ID: 26206621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.
    Ostermann H; Blasi F; Medina J; Pascual E; McBride K; Garau J;
    J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin Use in Patients Discharged From the Emergency Department: A Retrospective Observational Cohort Study.
    Mueller K; McCammon C; Skrupky L; Fuller BM
    J Emerg Med; 2015 Jul; 49(1):50-7. PubMed ID: 25802166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
    Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ
    Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
    McCollum M; Sorensen SV; Liu LZ
    Clin Ther; 2007 Mar; 29(3):469-77. PubMed ID: 17577468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
    Itani KM; Dryden MS; Bhattacharyya H; Kunkel MJ; Baruch AM; Weigelt JA
    Am J Surg; 2010 Jun; 199(6):804-16. PubMed ID: 20227056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
    Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP
    J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Chen S; Boulanger L; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.
    Garau J; Ostermann H; Medina J; Avila M; McBride K; Blasi F;
    Clin Microbiol Infect; 2013 Sep; 19(9):E377-85. PubMed ID: 23663184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.